002603 以岭藥業
按盤價 
17.460 -0.260 (-1.467%)
17.460 -0.260 (-1.467%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.834 | 12.085 | 23.626 | 14.941 | 14.450 |
| 總資產報酬率 ROA (%) | 3.303 | 8.118 | 16.158 | 11.016 | 11.854 |
| 投入資產回報率 ROIC (%) | 4.006 | 9.832 | 19.722 | 13.303 | 12.087 | 邊際利潤分析 |
| 銷售毛利率 (%) | 53.394 | 57.282 | 63.771 | 63.615 | 64.493 |
| 營業利潤率 (%) | 11.046 | 17.249 | 22.577 | 15.510 | 16.374 |
| 息稅前利潤/營業總收入 (%) | 10.962 | 16.578 | 22.346 | 15.529 | 16.176 |
| 淨利潤/營業總收入 (%) | 8.626 | 13.028 | 18.813 | 13.261 | 13.834 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 95.458 | 94.947 | 103.068 | 100.217 | 101.204 |
| 價值變動淨收益/利潤總額(%) | 5.857 | 3.877 | 0.414 | -1.409 | 2.081 |
| 營業外收支淨額/利潤總額(%) | -4.616 | -5.677 | -1.759 | -0.988 | -1.094 | 償債能力分析 |
| 流動比率 (X) | 1.570 | 1.472 | 1.496 | 1.892 | 2.438 |
| 速動比率 (X) | 1.077 | 0.919 | 1.079 | 1.327 | 1.733 |
| 資產負債率 (%) | 30.868 | 32.636 | 33.111 | 29.699 | 22.354 |
| 帶息債務/全部投入資本 (%) | 12.134 | 14.733 | 16.356 | 9.743 | -- |
| 股東權益/帶息債務 (%) | 692.631 | 554.734 | 495.085 | 889.909 | 1,802.472 |
| 股東權益/負債合計 (%) | 224.314 | 206.624 | 202.053 | 236.627 | 347.190 |
| 利息保障倍數 (X) | 27.196 | 64.873 | 140.593 | 90.712 | -773.474 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 109.849 | 72.012 | 47.934 | 48.812 | 0.000 |
| 存貨周轉天數 (天) | 200.205 | 182.969 | 146.462 | 159.076 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 15/11/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
